Group 1 - Organon & Co. (NYSE:OGN) is a women's health company focused on fertility and contraceptive products, recently facing controversy after CEO Kevin Ali's resignation due to an audit committee investigation [1] - Jim Cramer labeled Organon as potentially the "worst stock ever," highlighting issues with channel stuffing that occurred shortly after the company's spin-off from Merck on June 2, 2021 [1] - The audit committee found that Organon was involved in channel stuffing for multiple quarters, including the third and fourth quarters of 2024 and the first three quarters of 2025, indicating serious operational issues [1] Group 2 - Despite the controversies surrounding Organon, there is acknowledgment of its potential as an investment, although there is a belief that certain AI stocks may offer better returns with lower risk [1]
Jim Cramer’s “Worst Stock Ever” Might Be Organon (OGN)